Sign in or Register
  • Home
    • The story of Aurigene
    • The Aurigene approach
    • Our impact
    • Media center
    • Our publications
  • About Us
    • Our journey
    • Our purpose
    • Our Core Values
    • Our milestones
    • Management Team
    • Board of Directors
    • Scientific Advisors
  • Science
    • Science
      • Our research
      • Our platform technologies
      • Our publications
    • Pipeline
      • Proprietary Pipeline
      • Clinical Candidates from Partnered Programs
  • News and Events
    • Aurigene in the media
    • News
    • Events
  • Careers
    • Life at Aurigene
    • Working at Aurigene
    • Perks at Aurigene
    • Teamwork
    • Current Openings
    • A word from Aurigeneans
  • Contact Us
Aurigene
Home
  • Home
    • The story of Aurigene
    • The Aurigene approach
    • Our impact
    • Media center
    • Our publications
  • About Us
    • Our journey
    • Our purpose
    • Our Core Values
    • Our milestones
    • Management Team
    • Board of Directors
    • Scientific Advisors
  • Science
    • Science
      • Our research
      • Our platform technologies
      • Our publications
    • Pipeline
      • Proprietary Pipeline
      • Clinical Candidates from Partnered Programs
  • News and Events
    • Aurigene in the media
    • News
    • Events
  • Careers
    • Life at Aurigene
    • Working at Aurigene
    • Perks at Aurigene
    • Teamwork
    • Current Openings
    • A word from Aurigeneans
  • Contact Us
  1. Home
  2. Publication
  3. Page 8
April 28, 2023
by admin aurigene

Structure-Guided Discovery of 1,3,5 Tri-Substituted Benzenes as Potent & Selective Matriptase Inhibitors Exhibiting in Vivo Antitumor Efficacy

April 28, 2023
by admin aurigene

Discovery of azetidine based ene-amides as potent bacterial enoyl ACP reductase (FabI) inhibitors

April 28, 2023
by admin aurigene

3Alkoxy-pyrrolo[1,2b]pyrazolines as Selective Androgen Receptor Modulators with Ideal Physicochemical Properties for Transdermal Administration

April 28, 2023
by admin aurigene

Identification of a potent inhibitor of enoyl ACP reductase FabI from Burkholderia pseudomallei – crystal structure, Mode of Action and Biological Activity

April 28, 2023
by admin aurigene

Discovery and Optimization of a Novel Series of IRAK-4 Inhibitors for the Treatment of Autoimmune Disorders

April 28, 2023
by admin aurigene

Efficacy of Selective RAR-related Orphan Receptor gamma (RORγ) Inverse Agonists in Inflammatory Disease Models

April 28, 2023
by admin aurigene

Discovery of O-(3-carbamimidoylphenyl)-L-serine amides as matriptase inhibitors using a fragment-linking approach

April 28, 2023
by admin aurigene

Crystal structure of ATP-binding subunit of an ABC transporter from Geobacillus kaustophilus

April 28, 2023
by admin aurigene

Dihydroorotate Dehydrogenase (DHODH) Inhibitor Suppress Breast Cancer Cells Proliferation

April 28, 2023
by admin aurigene

AFN-1252 is a potent inhibitor of enoyl-ACP reductase from Burkholderia pseudomallei – Crystal structure, mode of action, and biological activity

1... 678910... 17
Home
  • Pipeline
  • Publications
  • Science
  • News and Events
  • Careers
Careers
Contact Us
Linkedin X-twitter

Governance

Code of Business Conduct
and Ethics

  • Statement of Policy
  • Link to Raise Concerns

Annual Reports

  • Link to View Report

Safety, Health, Environment
and Sustainability

  • Policy Statement and Reports

Information Security
Management System

  • ISO/IEC 27001:2022 Certificate

Policies

CSR

  • Commitee
  • Statement of Policy
  • Guiding Principles
  • Activities

Remuneration Policy

  • Statement of Policy

© 2022 Aurigene Discovery Technologies

Privacy & GDPR policy

Cookie policy

Crafted by: Pink Lemonade Communications Pvt. Ltd.

© 2022 Aurigene Oncology

Privacy and GDPR Policy

Cookie Policy

Apply Now